DISEASE STATE / MECHANISM OF ACTION
ASSET
NO. GENE TARGETS
REGULATORY PATHWAY
IP
STATUS
NEXT STEPS
depression
(moderate)
serokind™
10
medicinal
pat pending
trademark
Phase I Clinical
UK Medical Research Council Neuroscience & Mental Health Grant Award - awaiting decision
Vascular Dementia
VNDMA
3
medicinal
Patent
potential
R&D
Yield Optimisation
Feasibility Study
depression
(mild)
serotonin precursor
2
consumer
data
In-Market
Anhedonia
dopamine precursor
3
consumer
data
In-Market
In-market gene cluster to disease severity analysis
Memory
acetylcholine precursor
5
consumer
data
In-Market
longitudinal intervention efficacy data.
Cognition
tyrosine
1
consumer
data
In-Market
Alzheimer's dementia
Docosahexaenoic Acid
6
consumer
data
In-Market
Mild Cognitive Impairment
Blueberry Protect™
5
consumer
data
+
trademark
Market Ready
launch products
Aged-related Cognitive Fatigue
(Fatigability)
brain cell fuel™
8
consumer
data
+
trademark
Market Ready
In-market gene cluster to disease severity analysis
Alertness
Beyond Caffeine™
3
consumer
data
+
trademark
Market Ready
(US Only)
longitudinal intervention efficacy data.
Sleep
Sleep Easy™
6
consumer
data
+
trademark
Market Ready
(US Only)
depression
(moderate)
Asset
serokind™
Gene Targets
10
Pathway
medicinal
IP
pat pending
trademark
Status
Phase I Clinical
Next Steps
UK Medical Research Council Neuroscience & Mental Health Grant Award - awaiting decision
Vascular Dementia
Asset
VNDMA
Gene Targets
3
Pathway
medicinal
IP
Patent
potential
Status
R&D
Next Steps
Yield Optimisation
Feasibility Study
depression
(mild)
Asset
serotonin precursor
Gene Targets
2
Pathway
consumer
IP
data
Status
In-Market
Anhedonia
Asset
dopamine precursor
Gene Targets
3
Pathway
consumer
IP
data
Status
In-Market
Next Steps
In-market gene cluster to disease severity analysis
Memory
Asset
acetylcholine precursor
Gene Targets
5
Pathway
consumer
IP
data
Status
In-Market
Next Steps
longitudinal intervention efficacy data.
Cognition
Asset
tyrosine
Gene Targets
1
Pathway
consumer
IP
data
Status
In-Market
Alzheimer's dementia
Asset
Docosahexaenoic Acid
Gene Targets
6
Pathway
consumer
IP
data
Status
In-Market
Mild Cognitive Impairment
Asset
Blueberry Protect™
Gene Targets
5
Pathway
consumer
IP
data
+
trademark
Status
Market Ready
Next Steps
launch products
Aged-related Cognitive Fatigue
(Fatigability)
Asset
brain cell fuel™
Gene Targets
8
Pathway
consumer
IP
data
+
trademark
Status
Market Ready
Next Steps
In-market gene cluster to disease severity analysis
Alertness
Asset
Beyond Caffeine™
Gene Targets
3
Pathway
consumer
IP
data
+
trademark
Status
Market Ready
(US Only)
Next Steps
longitudinal intervention efficacy data.
Sleep
Asset
Sleep Easy™
Gene Targets
6
Pathway
consumer
IP
data
+
trademark
Status
Market Ready
(US Only)